ClinConnect ClinConnect Logo
Search / Trial NCT06656312

Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis

Launched by WEN-HSIN HUANG · Oct 22, 2024

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

Polyp Detection Ai Assisted System Endoscopy Deep Learning Colonoscopy

ClinConnect Summary

This clinical trial is studying a new technology called the ASUS AI-assisted system (EndoAim) to see if it can help doctors find polyps during colonoscopy, which is a common procedure to check for colorectal cancer. Colorectal cancer is a serious health issue, and this study is important because many polyps can be missed during routine screenings. The goal is to compare the results of colonoscopies done with and without the AI system to see if it improves the detection of polyps that could lead to cancer.

To participate in this trial, you need to be at least 20 years old and scheduled for a colonoscopy using specific equipment. You should also follow a low-residue diet and prepare your bowels beforehand. If you join, you'll be randomly assigned to have a colonoscopy with the AI system or without it, and the doctors will closely monitor how well the AI helps in finding polyps. This study is currently recruiting participants, and your health will be carefully evaluated throughout the process to ensure the best outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 20 or older.
  • 2. Undergoing colonoscopy using the Olympus series endoscopes.
  • 3. Following a low-residue diet and undergoing bowel preparation.
  • Exclusion Criteria:
  • 1. Poor bowel cleansing. Note: Evaluated as Poor or Inadequate according to the Aronchick scale.
  • 2. Incomplete colonoscopy (not reaching the cecum).
  • 3. Use of anticoagulant medications or abnormal coagulation function within the last 5 days.

About Wen Hsin Huang

Wen-Hsin Huang is a dedicated clinical trial sponsor with a focus on advancing innovative medical research and improving patient outcomes. With a robust background in clinical science and a commitment to ethical research practices, Wen-Hsin Huang oversees the design, implementation, and management of clinical trials across various therapeutic areas. The organization emphasizes collaboration with leading researchers and institutions to ensure the highest standards of scientific integrity and regulatory compliance. By fostering a patient-centered approach, Wen-Hsin Huang strives to contribute meaningful advancements in healthcare through the successful development of new therapies and treatments.

Locations

Taichung, , Taiwan

Taichung, North Dist., Taiwan

Patients applied

0 patients applied

Trial Officials

Wen-Hsin Huang, MD

Principal Investigator

China Medical University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported